ADMA Biologics Director Jerrold Grossman Purchases 6,400 Shares at $7.91

This Form 4 filing reports that Jerrold B. Grossman, a director of ADMA Biologics, Inc., purchased 6,400 shares of common stock on May 27, 2026, at a price of $7.91 per share in an open market transaction. Following this purchase, Grossman directly owns 520,284 shares, which includes 509,594 shares of common stock and 10,690 restricted stock units (RSUs) that vest in two tranches in August 2026 and February 2027. Additionally, Grossman has indirect ownership through various entities: 22,857 shares through Brookwood LLC (where he serves as managing member), 31,381 shares through the Jerrold Grossman 2019 Irrevocable Trust (where he serves as investment trustee), 38,294 shares through Genesis Foundation Inc. (where he is President), and 175 shares owned by his wife. The total transaction value was approximately $50,624.